MM2 Group Closes Large Transaction

Sale Valued at Over $650,000

Livingston, NJ, February 27, 2007 - MM2 Group, Inc. (OTCBB: MMGP) announced today that its wholly-owned subsidiary, Genotec Nutritionals, Inc., a New York based nutraceutical company which generates its sales through custom formulations for several large strategic partners and from the distribution of its branded products, has closed on a very large order for lemon flavored, odorless fish oil softgels.

The transaction is valued at over $650,000, which is to be delivered over the next 90 days. The Company is optimistic that the product will be ordered from the customer each of the next 3 quarters, which could make the order as large as $2.6 million per annum.

MM2 Group reported sales of $426,276 for the first six months of fiscal 2007. This sale dramatically increases the size and scope of the company.

Fish oil is known for being rich in unsaturated fatty acids and provides essential Omega-3 fatty acids (EPA and DHA). Fish oil may help reduce or inhibit risk factors involved in cardiovascular disease, cognitive decline, macular degeneration, as well as inflammatory and immune disorders. Omega-3 fatty acids also help prevent menopausal symptoms, promotes better circulation and neural development, and lowers cholesterol and triglycerides.

George Kontonotas, President of Genotec Nutritionals, stated "Genotec is committed to providing cutting edge products to the market in a timely fashion. This order is among the largest in the Company's history, and rapidly accelerates our growth plan. The additional financing available from our parent company (MM2 Group) has enabled us to aggressively expand our product development and our marketing efforts. We expect to announce several new products in the coming months, and we anticipate that our sales are going to continue to grow at a very rapid pace. "

Mark Meller, CEO of MM2 Group, added "This order comes on top of the tremendous reception our Sugarest™ product has received in the last week. Sugarest™ has appeared on over 18 television stations around the country, and orders are coming in at a tremendous rate. We have successfully positioned Genotec to grow into a very large company in the near future."

About MM2 Group, Inc.
MM2 Group is involved in the acquisition and build-out of dietary supplement and nutraceutical companies. The company's growth strategy is to acquire firms in this extensive and expanding but highly fragmented segment as it seeks to create substantial value for shareholders. For more information, contact MM2 Group CEO Mark Meller at (732) 290-0019 or by e-mail at meller@mm2group.net or Jerry Mahoney at jerrym@mm2group.net.

This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, regarding among other things our plans, strategies and prospects -- both business and financial. Although we believe that our plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, we cannot assure you that we will achieve or realize these plans, intentions or expectations. Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Many of the forward-looking statements contained in this news release may be identified by the use of forward-looking words such as "believe," "expect," "anticipate," "should," "planned," "will," "may," "intend," "estimated," and "potential," among others. Important factors that could cause actual results to differ materially from the forward-looking statements we make in this news release include market conditions and those set forth in reports or documents that we file from time to time with the United States Securities and Exchange Commission. All forward-looking statements attributable to MM2 Group, Inc. or a person acting on its behalf are expressly qualified in their entirety by this cautionary language.